Lake Street initiated coverage on Lifevantage with a new price target
$LFVN
Biotechnology: Pharmaceutical Preparations
Health Care
Lake Street initiated coverage of Lifevantage with a rating of Buy and set a new price target of $26.00
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 1/14/2025 | $35.00 | Buy | Craig Hallum |
| 12/19/2024 | $26.00 | Buy | Lake Street |
Craig Hallum initiated coverage of Lifevantage with a rating of Buy and set a new price target of $35.00
Lake Street initiated coverage of Lifevantage with a rating of Buy and set a new price target of $26.00